A Prospective, Open Label, Multicenter Study to Assess the Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients.
Phase of Trial: Phase IV
Latest Information Update: 01 Feb 2011
At a glance
- Drugs Ciclosporins; Mycophenolate sodium; Steroids
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Novartis
- 01 Feb 2011 Actual end date (Oct 2005) added as reported by ClinicalTrials.gov.
- 01 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Nov 2006 New trial record.